Skip to content

Insider · CIK 0001313325

Patricia A Bradford

director

Files at PHIO (Phio Pharmaceuticals Corp.). First filing Sep 16, 2026, latest Sep 25, 2026.

Patricia A Bradford files SEC Form 4 as director at PHIO (Phio Pharmaceuticals Corp.). Since Sep 16, 2026, Patricia A Bradford has reported 2 open-market buys worth $19k and 0 open-market sells worth $0, the latest filed on Sep 25, 2026.

A track record needs three past buys with six months of prices behind them; Patricia A Bradford has 0, so none is measured yet.

The newest scored trade: bought $6,583 of PHIO on Sep 24, 2026, filed Sep 25, 2026, scored 38 (weak). In the last 12 months: 2 buys worth $19k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$19k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PHIO: Phio Pharmaceuticals Corp.

PHIOOct 9, 2026 · close 0.98

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
38Weak
PHIObuy 3
Phio Pharmaceuticals Corp.
$6,583
6,500 shares
+11%-
36Weak
PHIObuy 3
Phio Pharmaceuticals Corp.
$12k
12,000 shares
+26%-

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 24, 2026PHIO
Phio Pharmaceuticals Corp.
POpen-market purchase
Common Stock, $.0001 par value
+6,500$1.01$6,58364,15118 d ago
Sep 15, 2026PHIO
Phio Pharmaceuticals Corp.
POpen-market purchase
Common Stock, $.0001 par value
+12,000$1.03$12k57,65127 d ago
Feb 5, 2026PHIO
Phio Pharmaceuticals Corp.
AGrant or award
Common Stock, $.0001 par value
+18,500$0.00$045,651Feb 6, 2026
Sep 11, 2025PHIO
Phio Pharmaceuticals Corp.
AGrant or award
Common Stock, $.0001 par value
+18,800$0.00$027,151Sep 15, 2025

Questions about Patricia A Bradford

Answered from the filings on this page, as of the latest one.

Is Patricia A Bradford buying or selling?

In the last 12 months Patricia A Bradford reported 2 open-market buys worth $19k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $6,583 of PHIO on Sep 24, 2026. Grants, option exercises and tax withholding are not counted.

How did Patricia A Bradford's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patricia A Bradford has 0.

Where does Patricia A Bradford file Form 4?

Patricia A Bradford has filed Form 4 at PHIO (Phio Pharmaceuticals Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Patricia A Bradford: insider trades and track record | InsiderTell